MAR-DAPSONE

marcan pharmaceuticals inc🇨🇦 Health Canada

Approval Id: bc8003c1abf9b632
Drug Approval Canada Name: MAR-DAPSONE
Product Name: MAR-DAPSONE
Status: Marketed
Status Date: 2018-11-13
Original Market Date: 2018-11-13
Din: 02481227
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 08:16.92
Atc Original: J04BA02 DAPSONE
Atc Name: j 04 ba 02
Aig Number: 0106115001
Company Name: marcan pharmaceuticals inc
Company Address: 2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2

DAPSONE

100 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

bc8003c1abf9b632

Type

Standard